Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Spectrum Pharmaceuticals Inc (NASDAQ:SPPI)
Recent Posts
Colombia Oil and Gas 2023 Congress – Status and Developments Prospects of Oil and Gas industry in Latin America
Mike The Pike Productions, Inc. (OTC: MIKP) Announces Virtual Shareholder Conference July 25, 2023
Künstliche Intelligenz im Kinderherz-Zentrum
Auri Inc. – Dividend, Retirement Timelines and Expectations
Auto Parts 4Less Group, Inc. Unveils Significant Business Progress and Future Plans in Latest Investor Update
Popular Post
-
Japanese Premier Declares COVID-19 State of Emergency in Tokyo
-
Expect Even More Unique Electric Cars Says Ferrari
-
4CABLE TV INTERNATIONAL, INC. ANNOUNCES SETTLEMENT OF THE MARQUIS TRADING DEBT, OPENING OF THE FIRST OF ITS KIND HIP RESTAURANT AND THE UNDERGOING OF REPAIRS AT THE CIGN FARM
-
BT and Ericsson Partners to Build Private 5G Networks
-
U.S Resumes Talks With Embattled Huawei CFO Meng Wanzhou
